Drug intelligence / Profile preview

astaxanthin-rich Phaffia rhodozyma extract

Development stage
Preclinical
Lead developer
NextFerm Technologies
Modality
Small Molecules
Administration
Oral
01

Overview

Astaxanthin-rich Phaffia rhodozyma extract is derived from the yeast *Phaffia rhodozyma* (now known as *Xanthophyllomyces dendrorhous*), a significant natural source of the potent antioxidant carotenoid, astaxanthin. [7, 8] Astaxanthin is the primary active component, making up approximately 80% of the total carotenoid content in the yeast. [6] The extract is utilized as a nutraceutical and dietary supplement for human consumption, and as a feed additive in aquaculture to pigment the flesh of farmed salmon and trout. [6, 7, 12, 18] The primary mechanism of action is its powerful antioxidant property, where astaxanthin neutralizes free radicals and reactive oxygen species, protecting cells from oxidative damage. [1, 2, 4, 5] Research has explored its anti-inflammatory, immune-modulating, and anti-cancer properties. [1, 2, 5] A preclinical study in a rat model of benign prostatic hyperplasia (BPH) showed the extract inhibited BPH development at a level comparable to finasteride, suggesting it could be a potential alternative therapy. [10, 13, 15] However, in a separate study on a rat model of prostate cancer, the extract did not show any chemopreventive activity.

Brand names
AstaFermAQUASTARed Star Phaffia Natural ColorEcotone Phaffia natural color
Other names
Phaffia yeast extractXanthophyllomyces dendrorhous extract

Beyond the preview

Go deeper on astaxanthin-rich Phaffia rhodozyma extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on astaxanthin-rich Phaffia rhodozyma extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call